Molecular Diagnostics Market Research Report 2018

Molecular Diagnostics has emerged as one of the largest and fastest growing segment in the IVD industry. It is the most dynamic and transformative areas of diagnostics, leading to advances in research and treatment that are revolutionizing healthcare across a wide range of diseases and health conditions and has been driven by accuracy, high sensitivity, fast turnaround time, easy workflow, and cost–effective testing.

More Details @ http://www.dpiresearch.com/report-details.php?P_ID=59

The global molecular diagnostics market is projected to reach more than US$ 30 Billion by 2021, at a CAGR of XX% from 2016 to 2021.The global market is mainly driven by chronic infections, growing geriatric population, increasing demand for personalized medicines, and R&D activities for biomarker identification equipped with emergence of new technology and applications. In addition, innovations in molecular diagnostics for treating cancer, government support for research and development, and high patient awareness levels are driving the growth of molecular diagnostic market.

 

North America dominates the global market of molecular diagnostics due to increasing incidence of infectious diseases and lifestyle associated diseases. North America controls more than 40% of the market share by the year 2021. Japan, China and India is expected to show high growth rates in the next six years in molecular diagnostics market.

 

On the basis of application, Molecular oncology tests have emerged as a significant rapidly growing market segment.  Oncology test controls nearly 25% market share by the year 2021. Other segments such as infectious diseases test and genetic testing is poised to be remarkable expansion in the near future. Growing demand for infectious diseases and genetic tests is an opportunity for global molecular diagnostics market.

 

In terms of technology,Biochips/Microarrays is the fastest growing segment and is expected to boom further within the forecast period. FISH & Innovations and PCR based test is expected to grow at the highest CAGR in the coming years.

 

On the basis of company,Roche is the leading company with more than 30% market share in the global molecular diagnostics market and is expected to hold its strong position in the market. Becton Dickinson, Myriad Genetics, Abbott and Qiagen is expected to robust market growth in the global molecular diagnostics market.

 

The Research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data and statistically–supported and industry–validated market data and projections with a suitable set of assumptions and methodology. It provides analysis and information by categories such as 1)Market and Forecast 2) Application Wise Market & Forecast 3) Geographical Market & Forecast 4)Technology Wise Market & Forecast 5) Company Wise Molecular Diagnostics Sales & Forecast 6) Market Growth Drivers & Challenges

 

Global Molecular Diagnostics Market has been analyzed from 6 viewpoints:

 

       1)        Market and Forecast

       2)        Application Wise Market & Forecast

       3)        Geographical Market & Forecast

       4)        Technology Wise Market & Forecast

       5)        Company Wise Molecular Diagnostics sales & Forecast

       6)        Market Growth Drivers & Challenges

 

The following application segments of the molecular diagnostics market are detailed with size and six year forecast.

 

  • Infectious Disease Testing
  • Cardiovascular Disease Testing
  • Oncology Testing
  • Neurological Disorders Testing
  • Food Pathogen Detection Testing
  • Genetic Testing
  • Blood Screening
  • Tissue Typing (HLA Testing)
  • Others Molecular Testing

 

Furthermore, the following technology segments of the molecular diagnostics market are detailed with size and six year forecast.

 

  • PCR Based Test
  • PCR Related Technologies
  • Non–PCR Test
  • Fish & Innovations Testing
  • Biochips/Microarrays
  • Biosensors
  • Molecular Imaging
  • Other Technologies

 

The report analyses the market based on regions and presents the forecast in terms of value for the next six years. Regions covered in the report include:

 

  • North America
  • Europe
  • Japan
  • China
  • India
  • Brazil
  • Mexico
  • Korea
  • Rest of the world

 

The following companies of the molecular diagnostics market are detailed with size and six year forecast.

 

  • Roche
  • Abbott Laboratories
  • Myriad Genetics
  • Qiagen
  • Cephied
  • Becton Dickinson
  • Biomerieux
  • Other Companies

Research You Can Trust:

This report is written by our research team, a dedicated group of analysts that knows the industry inside and out.

Data Sources

The information contained in this report is based on secondary sources.

Secondary Sources: Secondary data analysis and review involves collecting and analysing a vast array of information. Research team seeks information from different sources such as published articles, company websites, magazine articles, associations, trade journals, annual reports, newspapers, books, Government official websites and other paid database sources.

Europe Non–Invasive Prenatal Testing Market Research Report 2018

Europe Non–Invasive Prenatal Testing market is set to touch US$ 500 Million by 2025.
The market is driven by number of factors such as high incidence rate of babies born with down syndrome, no risk of miscarriage with NIPT test, shifting trend towards child bearing at advanced maternal age (35 years or older), rising focus on reimbursement for NIPT and increasing preference for non–invasive techniques over invasive methods.
“Europe Non–Invasive Prenatal Testing Market Research Report 2018” presents an in–depth assessment of the Europe non–invasive prenatal testing market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up–to–date industry data on the market situation and future outlook. The research includes historic data from 2014 to 2017 and forecasts until 2025.
The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, NIPT test volume, revenues and provides forecasts through 2025. A comprehensive analysis has been done on market share of country–based market. The report also includes assessment of comparative test analysis by companies. Key trends in terms of collaboration, partnership, merger & acquisition, venture capital investment, distribution and licensing agreement are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the Europe non–invasive prenatal testing market.
The superior geographic segments are identified in the report which studies NIPT test consumed and market revenue of the 15 countries. The countries included in this report are United Kingdom, Germany, Italy, Spain, France, Switzerland, Sweden, Belgium, Russia, Turkey, Netherland, Poland, Armenia, Moldova, Denmark from 2014 to 2017 and forecasts to 2025.
The report concludes with the profiles of major players in the Europe non–invasive prenatal testing market. The key market players are evaluated on various parameters such as company overview, NIPT test portfolios and latest development and trends of the non–invasive prenatal testing market.
The major European companies dominating this market for its products, services and continuous product developments are:
Ariosa Diagnostics (Roche), LifeCodexx AG, Premaitha Health PLC and NIPD Genetics
Major and Promising NIPT Test Available in the European Region are:
• Panorama
• MaterniT21 PLUS
• Harmony
• Verifi
• NIFTY
• IONA
• PrenaTest
• Veracity
Major European Countries Analyzed Under This Report are:
• United Kingdom
• Germany
• Italy
• Spain
• France
• Switzerland
• Sweden
• Belgium
• Russia
• Turkey
• Netherland
• Poland
• Armenia
• Moldova
• Denmark
Major European NIPT Test Companies Analysis
• Ariosa Diagnostics (Roche)
• LifeCodexx AG
• Premaitha Health PLC
• NIPD Genetics
Key questions answered in this research report:
• At what pace is the NIPT test market growing in Europe? What will be growth trend in future?
• What are the key drivers and inhibitors in the current market? What will be the impact of
   drivers and inhibitors in the future?
• What is the country revenue and forecast breakdowns? Which is the major country revenue
   pockets for growth in the NIPT test market?
• What are the various NIPT test available in the European region and how they are poised to
  grow?
• How is the market predicted to develop in the future?
• Who are the market players?

China In Vitro Diagnostics (IVD) Market Analysis

China in vitro diagnostics(IVD) market is anticipated to grow over US$ 11 Billion by 2025 with an impressive double-digit growth rate in the forecast period 2018 – 2025.
The market is driven by number of factors such as rising incidences of chronic lifestyle diseases, public health awareness, demand of tests in rural areas stimulated by the healthcare reform plan, increasing demand from the middle class for high–end products and an increase in the number of private hospitals and independent testing laboratories.
“China In Vitro Diagnostics (IVD) Market Analysis 2012 – 2017 and Forecast 2018 – 2025: Clinical Chemistry, Immunoassay, Molecular Testing, SMBG, Point of Care Testing (POCT), Hematology, Coagulation, Microbiology, Genetic Testing, Infectious Diagnostics, Histology and Cytology” presents an in-depth assessment of the in vitro diagnostics(IVD) market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outlook for in vitro diagnostics(IVD) in China. The research includes historic data from 2012 to 2017 and forecasts until 2025.
The report contains a granular analysis of the China in vitro diagnostics market segmentation by 11 applications and illustrative forecast to 2025. A comprehensive analysis has been done on market share of China in vitro diagnostics by application, end-user and company share by revenue.
The report also includes assessment of in vitro diagnostics regulation in China. Key trends in terms of partnerships and recent developments are analyzed with details. The report also explores detailed description of growth drivers, restraints, trends and opportunities of the China in vitro diagnostics market.
Market Segmentation by Application and Analysis (2012 – 2025)
•Clinical Chemistry
• Immunoassay
•Molecular Testing
• Self–Monitoring of Blood Glucose (SMBG)
•Point of Care Testing (POCT)
•Hematology
•Coagulation
•Microbiology
• Genetic Testing
• Infectious Diagnostics
• Histology and Cytology
The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:
• Roche Diagnostics
• Abbott Laboratories
• Siemens Healthineers
• Sysmex Corporation
• Mindray Medical International Limited
• Beckman Coulter Inc
• Shanghai Fosun Pharmaceutical Group
• Thermo Fisher Scientific Inc
• Hologic Inc
• Qiagen
• Cepheid
• Bio-Rad Laboratories Inc
• Da An Gene Co. Ltd
• Shanghai Kehua Bio–Engineering Co. Ltd.
The Latest Industry Data Included in this Report:
• China In Vitro Diagnostics Market Revenue & Forecast (2012 – 2025)
• China In Vitro Diagnostics Market Dynamics
• China In Vitro Diagnostics Market Segmentation by Application (2012 – 2025)
• China In Vitro Diagnostics Market Revenue Share by Application (2012 – 2025)
• China In Vitro Diagnostics Market, Company Share by Revenue, 2017
• China In Vitro Diagnostics Market Share by End-User (Hospitals, Homecare, Research Institutes, Independent laboratories),2017
• Assessment of In Vitro Diagnostics Regulation in China
• Major Partnership Deals in China In Vitro Diagnostics Market
• Recent Developments in China In Vitro Diagnostics Market
• Overview of Key Companies in China In Vitro Diagnostics Market